Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Kristen McEachern"'
Autor:
Chang Liu, Manish Patel, Gerald Falchook, Patricia LoRusso, Timothy Yap, Melissa Johnson, Kristy Kuplast-Barr, Ryan Abo, Erika Manyak, Lisa Cleary, Viviana Bozon, Sudha Parasuraman, Heike Keilhack, Kristen McEachern
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c69f81a7d6be48219521485df3d41f01
Autor:
Heike Keilhack, Kevin Kuntz, Sudha Parasuraman, Lisa A Beck, Christopher T Richardson, Viviana Bozon, Kristen McEachern, Kerren Swinger, Laurie B Schenkel, Jennifer R Molina, Nicholas Perl, Danielle Blackwell, Jonathan Novak, Harsimran Kaur, Kristy Kuplast-Barr, Colin Coutts, Elizabeth Mateer, Bin Gui, Kaiko Kunii, Melissa Vasbinder, Mario Niepel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e2a2ade259e4fdf6f3b23aaf753881
https://doi.org/10.26226/m.64199a03c37f0d0019bb7680
https://doi.org/10.26226/m.64199a03c37f0d0019bb7680
Autor:
Kurt A. Schalper, Lieping Chen, Ignacio Melero, Roy S. Herbst, David L. Rimm, Scott Gettinger, Katerina Politi, Konstantinos Syrigos, David Jenkins, Kristen McEachern, Justin F. Gainor, Matthew D. Hellmann, Vamsidhar Velcheti, Jose Luis Perez-Gracia, Maria D. Lozano, Luis D. Mejías, Maria Toki, Nikita Mani, Weilai Dong, Ti Badri, Jungmin Choi, Brian S. Henick, Jun Wang, Miguel F. Sanmamed, Ila Datar
Purpose:To determine the tumor tissue/cell distribution, functional associations, and clinical significance of PD-1, LAG-3, and TIM-3 protein expression in human non–small cell lung cancer (NSCLC).Experimental Design:Using multiplexed quantitative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006c934910e74e28f9518778872cbcd4
https://doi.org/10.1158/1078-0432.c.6527621
https://doi.org/10.1158/1078-0432.c.6527621
Autor:
Drew W. Rasco, Amita Patnaik, Kristen McEachern, Sharon Lu, Wei Guo, Lisa Blaydorn, Murali Beeram, Ellie Im, Amy Mirabella, Jasgit C. Sachdev, Hadi Danaee, Glen J. Weiss
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose New immuno-oncology therapies targeting programmed cell death receptor 1 (PD-1) have improved patient outcomes in a broad range of cancers. The objective of this analysis was to evaluate the PK, pharmacodynamics (PDy), and safety of dostarlim
Autor:
Timothy A. Yap, Andres Cervantes, Gerald S. Falchook, Manish R. Patel, Dejan Juric, Saiama N. Waqar, Erin L. Schenk, Geoffrey Shapiro, Valentina Boni, Cesar A. Perez, Barbara Burtness, Yana G. Najjar, Fabricio Racca, Katerin Rojas, Kristy Kuplast-Barr, Kristen McEachern, Manoj Samant, Viviana Bozón, Sudha Parasuraman, Melissa Johnson
Publikováno v:
Cancer Research. 83:CT109-CT109
Background: PARP7 is a stress-induced monoART that suppresses the cellular type I interferon (IFN) response following cytosolic nucleic acid sensing. RBN-2397 is a first-in-class PARP7 inhibitor that induces IFN and an adaptive immune response. The t
Publikováno v:
Cancer Research. 83:2508-2508
Introduction: PARP7, encoded by the TIPARP gene, is a monoART involved in cellular stress responses and with immunomodulatory functions in cancer. The PARP7 gene is amplified in a subset of squamous cell carcinomas and ongoing clinical studies are as
Autor:
Kristy Kuplast-Barr, Melissa Johnson, Manish Patel, Timothy Yap, Gerald Falchook, Patricia LoRusso, Ryan Abo, Chang Liu, Erika Manyak, Lisa Cleary, Viviana Bozon, Sudha Parasuraman, Heike Keilhack, Kristen McEachern
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPARP7 is a mono-ART that is upregulated in response to cellular stress (e.g., viral infection, cigarette smoke), and suppresses the Type I interferon (IFN) response following cytosolic nucleic acid sensing. RBN-2397 is a first-in-class PARP
Autor:
Jennifer R. Molina, Joseph M. Gozgit, Melissa M. Vasbinder, Ryan P. Abo, Kaiko kunii, Kristy G. Kuplast-Barr, Bin Gui, Sunaina P. Nayak, Elena Minissale, Kerren K. Swinger, Tim J. Wigle, Alvin Z. Lu, Danielle J. Blackwell, Christina R. Majer, Yue Ren, Ellen Bamberg, Mario Niepel, Jan-Rung Mo, William D. Church, Ahmed S. Mady, Jeff Song, Zacharenia A. Varsamis, Luke Utley, Patricia E. Rao, Timoty J. Mitchison, Kevin W. Kuntz, Victoria M. Richon, Kristen McEachern, Heike Keilhack
Publikováno v:
Cancer Research. 82:2154-2154
Targeting cytosolic nucleic acid sensing pathways to activate the Type I interferon (IFN) response is an emerging therapeutic strategy being explored in oncology. The PARP family consists of seventeen enzymes that regulate fundamental biological proc
Autor:
Kristy Kuplast-Barr, Melissa L. Johnson, Manish R. Patel, Timothy A. Yap, Gerald S. Falchook, Patricia LoRusso, Ryan Abo, Chang Liu, Erika L. Manyak, Lisa Cleary, Viviana Bozon, Sudha Parasuraman, Heike Keilhack, Kristen McEachern
Publikováno v:
Cancer Research. 82:1836-1836
Background: PARP7 is a mono-ART that is upregulated in response to cellular stress (e.g., viral infection, cigarette smoke), and suppresses the Type I interferon (IFN) response following cytosolic nucleic acid sensing. RBN-2397 is a first-in-class PA
Autor:
Radwa Sharaf, Kristen McEachern, Anupriya S. Kulkarni, Jodie Wong, David T. Ting, Katherine Xu, Heike Keilhack, Linda T. Nieman, Kristy Kuplast-Barr, Ryan Abo, Azfar Neyaz, Lee A. Albacker
Publikováno v:
Cancer Research. 81:381-381
PARP7 (TIPARP) is a monoPARP which catalyzes the transfer of single units of ADP-ribose onto substrates to change their function. Its expression is upregulated during cellular stress, including viral infection or through the activation of the aryl hy